MOG and myeloid sarcoma: Such discrepant findings parallel those in a well-established MS rodent model, namely experimental autoimmune encephalomyelitis triggered by myelin oligodendrocyte glycoprotein (MOG), in which both reduced αS expression[26], as well as increased levels are reported [27,28].